logo
Things just keep getting more difficult in China for Elon Musk's Tesla

Things just keep getting more difficult in China for Elon Musk's Tesla

Yahoo5 hours ago

Tesla is losing ground in China as local rivals gain market share and tech momentum.
Xiaomi says its YU7 SUV got 200,000 orders in 3 minutes, posing a serious threat to Tesla's Model Y.
Tesla's China sales fell 18% and its top manufacturing exec has reportedly left the company.
Tesla's China nightmare just deepened — again.
The latest blow came from Chinese smartphone and electric vehicle maker Xiaomi, which announced Thursday it had received close to 300,000 orders for its new YU7 electric SUV within an hour of its launch.
The YU7, priced at the equivalent of $35,000 in China, is a direct competitor to Tesla's best-selling Model Y, which starts at $36,760.
Xiaomi CEO Lei Jun didn't hold back during YU7's launch on Thursday, saying his company would "not accept defeat" and was officially taking up Tesla's long-standing challenge to compare products head-to-head.
The SUV's price edge, paired with better specs and sky-high local enthusiasm, could spell trouble for Tesla's operations.
"The new Xiaomi is probably Tesla's largest threat so far, not only in China but globally. It's very competitive and appealing," Felipe Muñoz, global analyst at JATO Dynamics, told Business Insider.
That threat goes beyond pricing and performance, according to Bill Russo, CEO of Shanghai-based consultancy Automobility.
"They're not just an EV company," he told Bloomberg TV. "They're creating a fully integrated digital ecosystem, value proposition, which, in China, the world's biggest digital economy, resonates very, very well."
Russo said Xiaomi is applying a "smartphone mindset" to vehicles — treating cars as digital terminals within a broader network of connected devices.
With more than 600 million Xiaomi-branded smart devices in use globally, that ecosystem advantage could drive deeper customer loyalty than traditional automakers can muster.
"They recognize this opportunity, they entered it, and in one year with one model, they're outselling Tesla in China," Russo said. "So I think you're going to see a pretty strong, positive momentum for this company going forward."
Xiaomi's first car, the SU7, went on sale in China last year. Ford's CEO has called it "fantastic," and Business Insider's reviewer concluded that the EV "simply shouldn't drive this well given it's from a company that has not produced vehicles before."
The YU7's launch comes at a difficult time for Tesla.
According to data from Shanghai-based consultancy ThinkerCar, Tesla's battery electric vehicle sales in China dropped 18% year-over-year between January and May 2025.
In contrast, rival BYD surged, selling 894,000 EVs globally over the same period, compared to Tesla's 603,000, overtaking it by a margin of 291,000 vehicles.
BYD also overtook Tesla in global revenue last year, bringing in $107 billion versus $97.7 billion for Tesla.
In April, BYD surpassed Tesla's sales in Europe for the first time, selling 7,230 battery-electric vehicles versus 7,165 for Tesla, according to JATO Dynamics data.
Muñoz said a key factor is Tesla's aging lineup, particularly the Model Y.
"It's about time to get an all-new generation," he said. "However, based on the strategy implemented with other models, it doesn't seem that an all-new Model Y is coming anytime soon."
He said that might not be a problem in the US or Europe, where Tesla still leads on specs and battery performance, but it is in China. "The rivals are catching up fast and the price war is very aggressive."
The growing pressure also seems to be straining operations.
On Thursday, multiple outlets reported that Omead Afshar, Tesla's VP of manufacturing and a longtime Musk ally, had left the company.
His departure follows that of Milan Kovac, head of the Optimus humanoid robot project, earlier this month.
"The dismissal of Afshar is part of the game and Tesla's response to the increasing challenges in China, considering that it can't react fast from a product point of view," Muñoz said. "The Model Y is still one of China's top sellers, but it is not alone anymore."
Meanwhile, Xiaomi is riding a wave of momentum. Its stock is up 72% this year, driven by EV success, smartphone dominance, and expansion into home appliances.
Still, Muñoz cautioned against writing off Tesla just yet.
"There's room for more models because the demand is still responding to the increasing offer. The YU7 is one of them, but it won't mean the defeat of Tesla," he said.
"It will complicate life, but Tesla has already built a reputation of excellent EVs and is a pioneer in the EV industry."
Not everyone is convinced Tesla can keep its edge. Russo noted that while Tesla led on software innovation, it lacks the localized integration that increasingly matters in China.
"Tesla, as a software pioneer, you get consideration," he said. "But quite frankly, they don't have the digital ecosystem localized in the way the Chinese consumer wants them."
Read the original article on Business Insider

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Regina doctors remove money from banks investing in Israeli arms industry
Regina doctors remove money from banks investing in Israeli arms industry

Yahoo

time26 minutes ago

  • Yahoo

Regina doctors remove money from banks investing in Israeli arms industry

Dr. Kieran Conway and several colleagues wanted to do something as news of killings continued to flow out of Gaza. 'There was a group of physicians that felt really demoralized by what was happening in Gaza and feeling quite powerless about what we could do,' said Conway in a recent interview. That's why he and his fellow physicians brought forward a motion to the Regina Medical Staff Association (RMSA) annual general meeting on June 24. It called for the transfer of all funds from major Canadian banks investing in arms manufacturing over to Saskatchewan-based credit unions. Conway, a family physician and hospitalist in Regina, was among the 21 people, or 75 per cent, who voted in favour of the motion which named Scotiabank and RBC. Six voted against. Elbit Systems and Scotiabank's investment in the defence company has come under increasing scrutiny for its role in supplying weapons — including loitering munitions more commonly referred to as 'suicide drones' — following Hamas' Oct. 7, 2023 attack on Israel in which 1,200 were killed and about 250 were taken hostage. It's difficult to assess the number of Palestinians killed in the 20 months of conflict following the Oct. 7 attack. Palestinian health authorities say more than 50,000, mostly civilians, have been killed, while the United Nations says that number is likely low. According to The Guardian, 879 Israeli soldiers have been killed since Oct. 7. The RMSA has the authority to make such decisions and the Saskatchewan Medical Association 'has no comment on it,' the SMA said an email response to questions from the Leader-Post. 'Individual securities are held based on their investment merit and are not influenced by protest activity,' Scotiabank said in an emailed statement provided Friday. And when it comes to holding of Elbit, 'Scotia Global Asset Management's exposure to Elbit Systems is 1.6 per cent of outstanding shares, as of March 31, 2025.' Past reporting from The Canadian Press indicated Scotiabank's 1832 Asset Management held 642,000 shares in Elbit at the end of second quarter 2024 which was down from about 2,237,000 shares in 2023. On Friday, Scotiabank said 1832 Asset Management holds 700,100 shares of Elbit as of March 31, 2025. Comment was sought from RBC as well, but no response was offered. Regina residents mark one-year anniversary of reignited conflict in Israel, Gaza Talk about Israeli-Palestinian conflict still on after city councillor prevents cancellation As of 2023, Scotiabank was one of the top five investors in Elbit Systems, Israel's largest weapons manufacture. Since then, the bank has reduced its holding in the company though it does still hold significant investments, according to reporting by Reuters. Between the two banks, the RMSA has more than a quarter-million dollars invested, which it will now move to local institutions. Doctors have a moral responsibility 'to stop it, and if we can't stop it, at least make sure that we're not supporting it anyway we can,' said Conway of the ongoing conflict. 'It's hard to know what to do from where we are. Myself, like all physicians, our role, the reason we came into this profession, is to support life,' he said. 'We've watched in horror as it seems Israel has tried to exterminate life in Gaza.' In early January, Médecins Sans Frontières (Doctors Without Borders) stated 'out of 36 hospitals in Gaza, Palestine, only 17 remained partially functional by early December 2024, with the other 19 closed, while over 1,000 health workers have been killed.' In 2024, a United Nations special committee found 'Israel's warfare in Gaza is consistent with the characteristics of genocide, with mass civilian casualties and life-threatening conditions intentionally imposed on Palestinians there.' Conway said other medical associations in Canada have tried to pass similar motions, but to his knowledge none have been successful. 'I hope this shows other medical associations and other professional associations, even outside of the medical field, that there are tangible things, there is action you can take to to oppose the genocide,' he said. alsalloum@

Accor Group CEO Sébastien Bazin: ‘Anybody who's waiting for the day after tomorrow is just an idiot'
Accor Group CEO Sébastien Bazin: ‘Anybody who's waiting for the day after tomorrow is just an idiot'

Yahoo

time27 minutes ago

  • Yahoo

Accor Group CEO Sébastien Bazin: ‘Anybody who's waiting for the day after tomorrow is just an idiot'

In today's CEO Daily: Diane Brady talks to Accor Group CEO Sébastien Bazin. The big story: Trump wants to name a new Fed chair early. The markets: The dollar is down again but the S&P remains near its all-time high. Analyst notes from Macquarie on 'war' at The Fed, JPMorgan on the S&P 500, Wedbush on stocks, and Oxford Economics on consumer sentiment. Plus: All the news and watercooler chat from Fortune. Good morning. Accor Group CEO Sébastien Bazin says he left the financial industry for a 'super narcissistic' reason: 'After 25 years in finance and being successful enough, I had no idea whether I was lucky or smart.' Turns out he's smart, having expanded the Paris-based hotel group from a portfolio of 13 economy to mid-scale hotel brands, mostly based in Europe, to a global hotel giant with 360,000 people working in 110 countries and 47 brands that include Fairmont, Raffles, Mövenpick, Ibis, Mercure and Novotel. After creating a 'monster that was super complex to run,' he split the business two years ago and hired three more CEOs to run different units, retaining oversight of the luxury and lifestyle division 'because this is probably where the danger is the greatest; it's all about execution and experience, so faster growth, greater risk.' Now, he's focused on sustainability, expansion in markets like India, and AI to help his people deliver better service. When it comes to decision making, he first trusts his instincts: 'What is my stomach telling me of that situation? Then I need to go to the heart, as it's going to tell me how the decision will impact others. And the brain tells you one thing, which is the timing upon which you need to make a decision. Anybody who starts with the brain will probably make the wrong decision 80% of the time.' From finance, he says, 'I learned the cost of a dollar and how to assess the risk of a dollar being invested.' At Accor, he learned that executing on a vision takes time. 'You need to put it on paper, share it with your board of directors and once you have their blessing, you need to actually explain it to your management team, so that they understand where you're going.' Luck aside, he offers three tips that have served him well over the years. 'Always be an actor in your own life; never a spectator,' he says. 'Anybody who's waiting for the day after tomorrow is just an idiot, because a decision made later is usually worse than one made today.' And he always tries to show up in a good mood. 'Your people may only see you once a quarter or once in a lifetime, and you owe that to them.' More news CEO Daily via Diane Brady at This story was originally featured on Sign in to access your portfolio

S&P 500 Roars Back 23%--Wall Street's Wildest Rebound Since Trump's Tariff Shock
S&P 500 Roars Back 23%--Wall Street's Wildest Rebound Since Trump's Tariff Shock

Yahoo

time31 minutes ago

  • Yahoo

S&P 500 Roars Back 23%--Wall Street's Wildest Rebound Since Trump's Tariff Shock

The S&P 500 (SPY) just punched through a new record, officially logging a 23% rebound from its April low. What changed? Trump dialed back the tariff chaos, claiming a trade deal with China has been signed, and the U.S. helped broker a ceasefire between Israel and Iranboth of which took pressure off oil markets and global nerves. Add in better-than-expected earnings and a surge of buybacks, and suddenly investors are back in risk-on mode. After a brutal selloff triggered by Trump's liberation day tariffs earlier this year, markets are now pivoting hard toward AI, resilience, and growth. Warning! GuruFocus has detected 7 Warning Sign with C. The rally's engine? Tech and industrials. Tesla (TSLA) bounced alongside high-beta names like Palantir (NASDAQ:PLTR), Robinhood (NASDAQ:HOOD), and Super Micro (NASDAQ:SMCI) all ripping since Trump's U-turn on April 9. On the industrials front, Howmet Aerospace (NYSE:HWM) is up 62%, while Uber (NYSE:UBER) and GE Vernova (NYSE:GEV) have each jumped 54% year-to-date. Even defensive plays like RTX (NYSE:RTX) and Deere (NYSE:DE) joined the party. According to Barclays and Citi, investors now believe the worst of the trade fear is in the rearview mirror. Citi's team even sees another 2.5% upside by year-end 2025 as AI tailwinds keep sentiment strong. Still, not everyone's sold. Credit cracks are showingbank lending is slowing, and delinquencies are ticking up. Morgan Stanley's Lisa Shalett warns the market's now even pricier than it was back in January when you measure it by forward earnings. Her take? Peak pessimism might be behind us, but we're not back to easy street just yet. But here's the kicker: traders aren't flinching. Volatility has collapsed, retail is buying the dip, and no one seems to care about tariffs anymore. The market doesn't discount the same event twice, Shalett said. Right now, it's growth seasonand the tape is acting like it. This article first appeared on GuruFocus.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store